-+ 0.00%
-+ 0.00%
-+ 0.00%

Kyverna appoints Ritesh Srivastava as chief legal and compliance officer

PUBT·06/22/2026 12:01:43
Listen to the news
Kyverna appoints Ritesh Srivastava as chief legal and compliance officer
  • Kyverna Therapeutics appointed Ritesh Srivastava as chief legal and compliance officer, effective June 22, 2026.
  • Move supports its transition toward commercialization as it advances miv-cel toward a potential first approval in stiff person syndrome.
  • Srivastava most recently served as general counsel at BPGbio, advising on R&D, commercialization planning, and operations.
  • He previously held senior compliance roles at Spectrum Pharmaceuticals and Avanir Pharmaceuticals, following earlier work as a federal prosecutor.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kyverna Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606220800PRIMZONEFULLFEED9749870) on June 22, 2026, and is solely responsible for the information contained therein.